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Summary  Synthesised  hydroxyapatite  (HAp)  exhibits  excellent  biocompatibility,  making  it  an
ideal candidate  for  use  as  a  hard  tissue  substitute  material.  Nanoscale-size  effects  and  surface
phenomena  impart  HAp  nanoparticles  with  unique  properties  compared  to  the  conventional-Composite;
Carrier;
Filler
sized HAp  ceramics.  Modiﬁcation  of  HAp  is  also  important  for  regulating  its  physiochemical
properties.  In  this  review,  methods  of  HAp  synthesis  and  modiﬁcation,  and  various  applications
of HAp  nanoparticles  for  dental  and  medical  treatment  are  discussed.
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c. Introduction
ertebrate  hard  tissues  consist  mainly  of  inorganic  com-
ounds  (Table  1  [1]),  collectively  termed  biological  apatite.
patite  is  a  general  term  for  crystalline  minerals  and  can  be
epresented  by  the  formula  M10(ZO4)6X2.  Each  component
M,  ZO4,  and  X)  in  the  formula  can  be  replaced  by  a  large
umber  of  different  ions  listed  below  [2]:
M  =  Ca2+,  Mg2+,  Sr2+,  Ba2+,  Mn2+,  Fe2+,  Zn2+,  Cd2+, Pb2+,  H+,
Na+,  K+,  Al3+,  etc.
ZO4 =  PO43−,  AsO43−,  VO43−,  SO42−,  CO32−,  SiO44−,  etc.
X  =  OH−,  F−,  Cl−,  Br−,  O2−,  CO32−,  vacancy,  etc.
The  most  common  apatite  found  in  nature  is  calcium
hosphate  apatite,  where  M  and  ZO4 are  Ca2+ and  PO43−,
espectively.  When  X  is  OH− (i.e.  Ca10(PO4)6(OH)2;  stoi-
hiometric  Ca/P  molar  ratio  is  1.67),  the  apatite  is  named
ydroxylapatite  [3],  traditionally  also  called  as  hydroxyap-
tite  (HAp).
Stoichiometric  HAp  belongs  to  a  hexagonal  crystal  system
4]  and  has  two  major  crystal  planes:  a  plane  and  c plane
Fig.  1).  It  is  widely  believed  that  the  a  plane  is  rich  in  cal-
ium  ions  and  hence  positively  charged,  whereas  the  c  plane
s  rich  in  phosphate  and  hydroxide  ions  and  hence  negatively
harged  [7,8].  That  is,  HAp  surfaces  exhibit  anisotropic
haracteristics  such  as  anisotropic  adsorption  proﬁles  for
iomolecules  [8].  Note  that  the  surface  ion  composition  (and
ence,  the  surface  charge)  of  HAp  in  aqueous  medium  varies
ccording  to  the  ion  composition  of  the  medium  because  of
on  exchange  [9]  and  gradual  dissolution  [10].Synthetic  HAp  sintered  ceramics  (in  dense,  porous,  and
ranular  forms)  have  been  used  in  dental  and  medical
elds  [2,11,12],  and  their  applications  include  alveolar
idge  reconstruction  and  augmentation  [13],  ﬁllers  for  bone
Table  1  Comparative  compositions  (wt%)  of  bone,  dentine,
and enamel  [1].
Bone  Dentine  Enamel
Ca  34.8  35.1  36.5
P 15.2  16.9  17.7
Na 0.9  0.6  0.5
K 0.03  0.05  0.08
CO2 7.4  5.6  3.5
F 0.03  0.06  0.01
Total inorganics  65  70  97
Total organics  25  20  1.5
Water 10  10  1.5
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mefects  [14],  and  middle  ear  implants  [15].  HAp  is  bioactive
osteoconductive);  thus,  HAp  has  the  ability  to  encourage
one  growth  along  its  surface  when  placed  in  the  vicinity  of
iable  bone  or  differentiated  bone-forming  cells  [16].  HAp
s  one  of  many  types  of  calcium  orthophosphates  listed  in
able  2  [17],  and  some  other  calcium  phosphates  that  show
igher  solubility  than  HAp  have  been  also  used  in  dental  and
edical  ﬁelds  [17,18].
Biological  apatite  is  a  non-stoichiometric  form  of  HAp
ontaining  trace  ions  and  deﬁcient  Ca2+.  The  trace  ions
nclude  positively  charged  ions  (such  as  Mg2+, Na+,  and
+) and  negatively  charged  ions  (such  as  CO32−,  Cl−,
nd  F−),  and  the  most  common  substituting  ion  is  car-
onate  (CO32−),  which  can  replace  OH− and  PO43−,
espectively  [4]. Depending  on  the  hard  tissue  type,  bio-
ogical  apatite  exhibits  different  crystal  morphologies.  For
xample,  in  bone  tissue,  the  c  axes  of  crystallites  (ca.
0  nm  ×  25  nm  ×  4  nm  [19]) are  parallel  to  the  extending
ollagen  ﬁbres,  resulting  in  the  exposure  of  the  a  planes
n  the  bone  surface.  In  contrast,  in  tooth  enamel,  larger
rystallites  (ca.  100  m  ×  25  nm  ×  70  nm  [20])  form  enamel
risms  extending  from  the  dentino-enamel  junction,  result-
ng  in  c-planes  that  are  preferentially  parallel  to  the  enamel
urface.
Nanoparticles  (nanopowders,  nanocrystals,  or  nanostruc-
ured  particles)  are  microscopic  particles  with  at  least  one
imension  in  the  nanometer  scale  (usually,  100  nm  or  less).
n  general,  nanoparticles  offer  improved  properties  com-
ared  with  conventional-sized  materials  because  of  their
arge  surface-to-volume  ratio  (speciﬁc  surface  area)  [21].  To
ontrol  the  properties  of  HAp  nanoparticles,  it  is  important
o  control  the  particle  morphology  (the  exposure  of  their  a
nd  c  planes),  which  can  be  achieved  by  adjusting  their  syn-
hesis  methods.  Modiﬁcation  of  HAp  is  also  important  for  the
egulation  of  its  physiochemical  properties.  This  paper  pro-
ides  a  summary  of  existing  knowledge  and  recent  progress
n  HAp  nanoparticles,  from  synthesis  and  modiﬁcation  to
ental  and  medical  applications.
. Synthesis methods for HAp nanoparticles
Ap  nanoparticles  can  be  synthesised  via  various  methods
hat  are  categorised  as  solid-state  and  wet-state  methods
Table  3).
.1.  Solid-state  methodsolid-state  methods  are  solid-state  reactions  between  raw
aterial  powders  (e.g.  CaHPO4 and  CaO)  induced  by  ther-
al  treatments,  and  they  usually  give  stoichiometric  and
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Figure  1  Crystal  structure  [5]  and  schematic  illustration  of  stoichiometric  hydroxyapatite  (HAp).  HAp  contains  both  cations  and
anions in  its  structure  and  has  high  afﬁnity  for  organic  molecules.  The  blue,  white,  red  and  yellow  spheres  are  Ca,  P,  O,  and  OH
s
t
a
c
trespectively.  The  crystal  structure  is  drawn  with  VESTA  3.2.1
Source:  Momma  and  Izumi  [6].
well-crystallised  HAp,  but  require  relatively  high  tempera-
tures  (mostly  exceeding  700 ◦C)  and  long  treatment  times
[22,23].  Additionally,  HAp  synthesised  via  solid-state  meth-
ods  is  generally  a  sintered  bulk,  and  therefore,  milling
or  grinding  is  necessary  to  obtain  nanoparticles  [24]. A
mechanochemical  method  through  direct  ball  milling  for  the
mixture  of  raw  materials  can  also  be  used  to  fabricate  HAp
nanoparticles  in  solid  state  [25,26].  Omori  et  al.  recently
developed  a  Pechini-based  method,  a  type  of  homogeneous
d
f
a
Table  2  Major  calcium  phosphates  and  their  properties  [16].
Ca/P  molar  ratio Chemical  formula Name  
0.5 Ca(H2PO4)2·H2O  Monocalcium
phosphate
monohydrate
0.5 Ca(H2PO4)2 Monocalcium
phosphate  anh
1.0  CaHPO4·2H2O  Dicalcium  pho
dihydrate  (bru
1.0 CaHPO4 Dicalcium  pho
anhydrous  (mo
1.2—2.2  CaxHy(PO4)z·nH2O
(n =  3—4.5)
Amorphous  ca
phosphate
1.33  Ca8(HPO4)2(PO4)4·5H2O  Octacalcium
phosphate
1.5 -Ca3(PO4)2 -Tricalcium
phosphate
1.5  -Ca3(PO4)2 -Tricalcium
phosphate
1.5—1.67  Ca10-x(HPO4)x(PO4)6-x(OH)2
(0  <  x  <  1)
Calcium-deﬁc
hydroxyapatit
1.67 Ca10(PO4)6(OH)2 Hydroxyapatit
2.0 Ca4(PO4)2O  Tetracalcium
phosphate
(hilgenstockit
a Stable at above 100 ◦C.
b Cannot be measured precisely.
c Always metastable.
d These compounds cannot be precipitated from aqueous solutions.olid-state  method,  to  obtain  well-crystallised  HAp  nanopar-
icles  without  milling  [27]:  a mixture  of  HAp  nanocrystals
nd  CaO  matrix  was  ﬁrst  prepared  under  non-stoichiometric
onditions  (Ca/P  molar  ratio    1.67)  at  1000 ◦C,  and  then
he  CaO  matrix  was  removed  by  washing  to  obtain  well-
ispersible  HAp  nanoparticles.
The  plasma  technique  is  another  physical  method  to
abricate  nanoparticles  in  a  solid  state.  Khor  et  al.  used
 radiofrequency  plasma  spray  process  to  fabricate  HAp
Abbr.  Water  solubility
at  25 ◦C  (g/L)
pH  stability
range  at  25 ◦C
MCPM  ∼18  0—2
ydrous
MCPA  ∼17 a
sphate
shite)
DCPD  ∼0.088  2—6
sphate
netite)
DCPA  ∼0.0048 a
lcium ACP b ∼5—12c
OCP  ∼0.0081  5.5—7
-TCP  ∼0.0025 d
-TCP  ∼0.0005 d
ient
e
CDHA  ∼0.0094  6.5—9.5
e  HAp  ∼0.0003  9.5—12
e)
TTCP  ∼0.0007 d
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Table  3  Synthesis  methods  for  HAp  particles.
Typical  particle  sizea Morphology  control  Crystallinity b Ref.
Solid  state  Solid-state  reaction  —  Impossible  High  [22,23]
Ball  milling  200—500  nm  Poor  High  [24]
Selective  dissolution  of  binary  phase  70—500  nm  Poor  High  [27]
Calcination  with  anti-sintering  agents  50—300  nm  Easy  High  [29]
Mechanochemical  methods  Micron  order  Poor  Poor  [25,26]
Plasma  spraying  100  nm  Poor  Poor  [28]
Wet  state  Wet  chemical  precipitation  50—500  nm  Easy  Poor  [29—32]
Homogeneous  precipitation
Thermal  pH  change Micron  order Easy  High  [34—38]
Thermal  dissociation  of  Ca  ions 30—500  nm Easy  High  [39,40]
Micelle-templated  precipitation  30—500  nm  Easy  Poor  [41,42]
Emulsion  method  30—100  nm  Easy  Poor  [43,44]
Hydrothermal  conversion  Micron  order  Easy  High  [45—52]
Hydrothermal  crystal  growth 30—100  nm  Easy  High  [53—56]
Sol—gel  method —  Poor  Amorphous  [57—60]
a Note that this value does not show the crystal size; rather, it shows the size of particles (including polycrystals or agglomerates) as
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b Samples without thermal treatment.
anoparticles  (particle  size,  10—100  nm),  which  contained
oth  amorphous  and  crystalline  phases  [28].
.2.  Wet-state  methods
et-state  methods  require  relatively  low  temperatures,
nd  nanoparticles  can  be  easily  synthesised.  However,  their
rystallinity  and  Ca/P  ratio  are  lower  than  those  of  the
ell-crystallised  stoichiometric  HAp  synthesised  by  solid-
tate  methods  in  many  cases;  that  is,  well-crystallised  HAp
an  be  obtained  only  at  elevated  temperatures  via  post
reatments  such  as  hydrothermal  treatments  and  calcina-
ion  under  wet  and  dry  conditions,  respectively.  Although
alcination  in  the  dry  state  induces  the  sintering  of  HAp
anoparticles,  a  novel  calcination  method  was  developed
o  synthesise  well-dispersible  HAp  nanocrystals  [29].
Precipitation  methods  (wet  chemical  precipitation)
30,31]  have  been  widely  used  among  the  wet-state  methods
ecause  they  are  simple.  Simple  mixing  of  two  aqueous  solu-
ions  of  calcium  and  orthophosphate  (at  pH  >  7)  results  in  the
ormation  of  highly  supersaturated  solutions  of  HAp,  which
nduces  rapid  precipitation  of  nanoparticles  [31]  according
o  the  following  reactions:
0Ca(OH)2 +  6H3PO4 →  Ca10(PO4)6(OH)2 +  18H2O  (1)
0Ca(NO3)2 +  6(NH4)2HPO4 +  8NH4OH  →  Ca10(PO4)6(OH)2
+  20NH4NO3 +  6H2O  (2)
The  morphology  of  HAp  nanoparticles  depends  on  the
recipitation  conditions  such  as  the  concentration  of  reac-
ants,  ionic  strength,  pH,  and  temperature  [21,32]  (Fig.  2).
he  mixing  condition  of  the  reactants  and  the  composi-
ion  of  the  medium  are  also  important  factors.  Iijima  et  al.
eveloped  a  cation-selective  membrane  system  and  found
c
l
s
f
Y co-operative  role  of  amelogenin  and  ﬂuoride  in  the  reg-
lation  of  crystal  orientation  and  phase,  resulting  in  the
ormation  of  ﬁne  rod-like  apatite  whose  orientation  was
imilar  to  that  of  authentic  tooth  enamel  crystals  [33].
Homogeneous  precipitation  methods  start  with  a  homo-
eneous  solution  of  calcium  phosphate  (dissolved  under
cidic  conditions),  and  nucleation  and  growth  of  HAp  are
nduced  by  thermal  decomposition  of  urea  (Eq.  (3))  [34,35]
r  acetamide  (Eq.  (4)) [36]:
NH2)2CO  +  H2O  →  CO2 +  2NH3 (3)
H3CONH2 +  H2O  →  CH3COOH  +  NH3 (4)
The  resultant  NH3 increases  the  solution  pH  and  degree
f  supersaturation  for  HAp,  leading  to  the  formation
precipitation)  of  HAp  particles.  Slow  hydrolysis  of  the
olecules  at  high  temperature  leads  to  the  formation  of
arge  and  well-crystallised  HAp  particles.  The  hydrolysis  of
rea  is  accelerated  by  the  addition  of  an  enzyme  (ure-
se),  especially  at  low  temperatures  [37].  Aizawa  et  al.
ecently  synthesised  plate-shaped  HAp  particles  with  pre-
erred  exposure  of  c  planes  by  a  homogeneous  precipitation
ethod  using  an  enzymatic  reaction  involving  urea  [38].
he  hydrothermal  treatment  of  the  homogeneous  calcium
hosphate  solution,  in  which  calcium  ions  are  dissolved  by
helation  with  ethylenediaminetetraacetic  acid  (EDTA)  [39]
r  citric  acid  [40], also  leads  to  the  formation  of  HAp  parti-
les  because  of  thermal  dissociation  of  calcium  chelates  in
hosphate  solutions.
Micelle-templated  precipitation  methods  are  conducted
n  the  presence  of  surfactant  micelles  as  a  nanostructured
emplate  [41,42].  Micelles  form  when  the  concentration
f  surfactant  molecules  is  higher  than  the  critical  micelle
oncentration  (CMC).  The  shape  (sphere,  cylinder,  or  lamel-
ar)  and  size  of  a  micelle  can  be  controlled  by  the
urfactant  molecular  geometry  and  solution  conditions  (sur-
actant  concentration,  temperature,  and  ionic  strength).
ao  et  al.  utilised  a  micelle-templated  method  for  preparing
Synthesis  and  modiﬁcation  of  apatite  nanoparticles  for  dental  and  medical  applications  89
Figure  2  Scanning  electron  microscopy  (SEM)  images  of  HAp  nanoparticles  with  different  particle  sizes  prepared  by  precipitation
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nmethods under  different  conditions.
mesoporous  HAp  nanoparticles  with  3-nm-sized  channels
[41].  Ye  et  al.  reported  micelle-templated  synthesis  of  HAp
hollow  nanoparticles  or  nanotubes  (diameter  of  approxi-
mately  35  nm,  length  of  50—250  nm,  and  hollow  diameter
of  13  nm)  with  polymeric  surfactants  [42].
Emulsion  methods  involve  precipitation  in  a  restricted
space  to  form  small  aqueous  droplets  stabilised  in  an  oil
phase  with  surfactant  molecules  [43,44].  Morphology  con-
trol  of  HAp  nanoparticles  can  be  achieved  by  restricting
crystal  growth,  and  this  surfactant-based  process  can  inhibit
excessive  agglomeration  of  the  particles.  For  example,  Lim
et  al.  have  prepared  HAp  nanoparticles  by  reacting  CaCl2 and
(NH4)2HPO4 in  an  inverse  microemulsion  formed  with  non-
ionic  surfactants  in  cyclohexane  [43],  and  they  found  that
the  microemulsion  route  led  to  signiﬁcant  reﬁnement  of  the
particle  size  and  degree  of  particle  agglomeration  compared
with  the  particles  obtained  by  a  conventional  wet  chemical
precipitation.
The  hydrothermal  conversion  methods  involve  hydroly-
sis  of  calcium  phosphates  (CaHPO4,  Ca8(HPO4)2(PO4)4·5H2O,
Ca3(PO4)2,  chlorapatite,  and  ﬂuorapatite)  [45—47]  or  poorly
soluble  calcium  salts  (CaCO3 [48,49]  and  CaSO4·2H2O
[50,51])  into  HAp  in  aqueous  medium,  generally  under
high  temperature  and  pressure,  by  using  calcium,  phos-
phate,  and/or  alkaline  sources  to  control  the  Ca/P  ratio
of  the  products.  Microwave  irradiation  [52]  can  be  used
rather  than  conventional  heating  in  pressure-resistant  ves-
sels.  Hydrothermal  conversion  methods  generally  lead  to
the  formation  of  large  crystalline  HAp  because  of  the  low
number  of  nucleation  sites.
s
c
n
CHydrothermal  crystal  growth  methods  are  post  treat-
ents  for  low-crystallised  HAp  nanoparticles  (prepared
y  wet  chemical  precipitation  in  many  cases)  in  aqueous
edium.  The  dimensions  of  the  precipitated  HAp  nanoparti-
les  increase  by  Ostwald  ripening  (maturation)  under  boiling
r  ambient  ageing  in  aqueous  media  [53,54].  Pathi  et  al.
ecently  reported  a  two-step  hydrothermal  method  to  obtain
Ap  nanoparticles  with  varying  crystallinity  and  average
ength  (32—103  nm)  [55]. Some  recent  attempts  at  prepar-
ng  nanostructured  HAp  hollow  particles  without  templates
id  meet  with  some  success.  For  example,  Nathanael  et  al.
eported  template-free  formation  of  HAp  nanorings  with  an
nner  diameter  of  70  nm  by  a  combined  high-gravity  and
ydrothermal  crystal  growth  approach  [56].
Sol—gel  methods  have  been  used  for  fabricating  ﬁne
eramics  in  liquid  medium,  typically  with  metal  alkoxide
recursors  that  undergo  hydrolysis  and  polycondensation
eactions  to  form  a  solid  phase  [57].  The  sol—gel  method
ith  calcium  alkoxides  and/or  phosphorus  alkoxides  is  also
n  effective  way  to  fabricate  nanostructured  HAp  sintered
eramics  [58,59]. The  obtained  solid  phase  generally  con-
ists  of  amorphous  Ca—P  intermediates  (and/or  the  mixture
f  unreacted  precursors),  and  hence,  a  thermal  treatment
generally  at  400—500 ◦C,  which  is  lower  than  the  sintering
emperature  of  HAp  powder,  approximately  800—1000 ◦C)  is
ecessary  to  obtain  well-crystallised  HAp.  The  products  of
ol—gel  methods  are,  therefore,  obtained  in  a  sintered  poly-
rystalline  form,  and  hence,  grinding  or  milling  is  usually
ecessary  to  obtain  HAp  in  the  nanoparticle  form.  Recently,
osta  et  al.  prepared  microspheres  consisting  of  nanosized
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Ap  wires  (25—800-nm  thick)  by  a  combination  of  sol—gel
nd  hydrothermal  (conversion)  processes  [60].
. Modiﬁcation of HAp nanoparticles
.1.  Ion  substitution
odiﬁcation  of  HAp  has  shown  remarkable  ﬂexibility  for
egulation  of  its  properties.  Ion  substitution  with  cations
such  as  Mg2+,  Sr2+,  Zn2+,  Fe3+,  and  Ag+)  and/or  anions  (such
s  CO32−,  SiO43−,  and  F−)  is  one  of  the  ways  to  alter  its
iocompatibility,  sinterability,  and  mechanical  properties
61,62].  For  example,  conventional  HAp  sintered  ceram-
cs  are  hardly  resorbed  after  implantation  [63],  which  is
uite  different  from  natural  bone  minerals,  whereas  CO3-
ubstituted  apatite  nanoparticles  exhibit  physicochemical
haracteristics  similar  to  those  of  bone  minerals  [64]. Sr
ubstitution  has  been  also  found  to  increase  the  solubility  of
patite  [65].  Sr  is  found  in  the  mineral  phase  of  bone,  espe-
ially  in  new  bones  [66],  and  Sr  substitution  has  a  positive
ffect  on  osteoblasts  for  enhancing  alkaline  phosphatase
ALP)  activity,  collagen  type  I  production,  and  osteocalcin
evels  [67].  Recent  results  demonstrated  the  regulation  of
inc  (Zn)-substituted  apatite  and  increased  performance  in
erms  of  protein  adsorptive  capacity  [68]  and  increased  pro-
iferation  rate  of  osteoblast  cells  in  vitro  [69].  However,
iocompatibility  is  affected  by  the  concentration  of  metals;
he  threshold  concentration  of  Zn  is  reported  to  be  1.2  wt%,
bove  which  Zn  ions  cause  cell  toxicity  [69].
.2.  Modiﬁcation  with  organic  molecules
odiﬁcation  with  organic  molecules  is  an  alternative  way  to
lter  the  surface  properties  of  HAp.  Surfactant  molecules
70],  alcohol  [71],  carboxylic  acids  [72], poly(ethylene
mine)  [73],  phosphonate-modiﬁed  poly(ethylene  oxide)
74],  poly(vinyl  alcohol)  [75],  and  biopolymers  [76]  can  be
dsorbed  on  HAp  surfaces,  and  thus,  HAp  surfaces  can  be
odiﬁed  by  additives.  The  addition  of  these  molecules  dur-
ng  wet-state  synthesis  (in  situ  modiﬁcation)  also  induces
orphological  changes  in  HAp  nanoparticles  through  inhi-
ition  of  crystal  growth  by  preferential  adsorption  of  the
dditives  onto  a  HAp  surface.  In  situ  modiﬁcation  with  amino
cids  is  also  important  for  controlling  the  morphology  and
urface  charge  of  HAp  nanoparticles  [77—79].  For  example,
i
o
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igure  3  HAp  nanoparticle-assembled  blocks  prepared  with  nano
tate; (c)  pore  size  distribution.M.  Okada,  T.  Matsumoto
Ap  synthesised  in  the  presence  of  glycine,  serine,  aspar-
ic  acid,  and  glutamic  acid  showed  morphological  changes
nd  increased  solubility  compared  to  HAp  synthesised  in  the
bsence  of  amino  acids;  other  amino  acids  (alanine,  valine,
roline,  threonine,  hydroxyproline,  methionine,  arginine,
nd  histidine)  did  not  affect  the  crystallinity,  morphology,
r  solubility  of  HAp  [78].  It  has  also  been  demonstrated
hat  incorporation  of  aspartic  acid  onto  the  HAp  surface
nhanced  the  adsorption  of  basic  proteins  because  of  the
dditional  carboxyl  groups  of  aspartic  acid  [79]. Wu  et  al.
ecently  revealed  that  the  chirality  of  the  additives  plays  an
mportant  role  in  the  asymmetric  crystal  growth  of  apatite
80]  by  using  the  L- or  D-forms  of  glutamic  acid  or  aspartic
cid.
The  surfaces  of  HAp  nanoparticles  can  be  also  modiﬁed
ith  the  above-mentioned  organic  molecules  after  synthesis
post  modiﬁcation).  Post  modiﬁcation  has  the  advantaged
f  separation  of  morphological  control  and  surface  modi-
cation;  that  is,  the  broadening  of  the  choice  of  organic
olecules.  For  example,  the  well-crystallised  nanoparti-
les  prepared  via  hydrothermal  treatments  can  be  modiﬁed
ith  thermally  instable  molecules  (such  as  biomolecules).
n  addition,  chemical  modiﬁcation  of  the  HAp  surface  via  a
ovalent  linkage  can  be  achieved  by  post  modiﬁcation  with
ilane-coupling  agents  [81]  or  isocyanates  [82,83].
. Applications of HAp nanoparticles
.1.  Building  block  for  nanostructured  ceramics
Ap  nanoparticles  were  found  to  exhibit  improved  sinter-
bility  (densiﬁcation)  [84,85].  Nanostructured  HAp  ceramics
re  also  expected  to  have  better  bioactivity  than  conven-
ional  HAp  ceramics  (consisting  of  coarser  crystals)  because
f  their  nanoscale  topography  [86—88].  For  example,  Web-
ter  et  al.  showed  enhanced  osteoclast-like  cell  adhesion
nd  function  on  nanophase  HAp  ceramic  surfaces  [86,87].
un  et  al.  reported  that  nanophase  HAp  promotes  the
roliferation  and  osteogenic  differentiation  of  periodon-
al  ligament  cells  compared  to  dense  HAp  [88].  Recently,
anoparticle-assembled  HAp  plates  with  nanosized  pores
nside  the  plate  were  prepared  by  simply  drying  an  aque-
us  dispersion  of  HAp  nanoparticles  on  a  liquid  substrate  at
0 ◦C  without  binder  molecules  (Fig.  3)  [89,90].  Feng  et  al.
eveloped  a  novel  two-step  sintering  process  (selective  laser
particles  with  different  particle  sizes:  (a)  dry  state;  (b)  wet
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sintering  (SLS)  followed  by  isothermal  sintering  at  a  lower
temperature)  for  fabricating  nanostructured  HAp  scaffolds
with  high  mechanical  strength  and  an  interconnected  macro-
porous  structure  [91].
4.2.  HAp  nanocomposites
HAp/polymer  composites  have  been  developed  to  overcome
the  inferior  mechanical  properties  (brittleness  and  low  stiff-
ness)  of  traditional  HAp  sintered  ceramics  (or  to  improve
bioactivity  of  the  polymer  matrix)  [92].  The  original  con-
cept  of  the  bioceramics/polymer  composite  was  introduced
by  Bonﬁeld  et  al.  [93],  based  on  the  concept  that  bone  tis-
sue  comprises  an  organic  matrix  reinforced  with  a  mineral
component.  The  bone  analogue  HAp/polyethylene  compos-
ite  combines  the  bioactivity  of  HAp  with  the  toughness
of  polyethylene.  Further  combination  with  other  organic
materials  such  as  poly(lactide-co-glycolide)  (PLGA)  [94,95],
collagen  [96,97],  ﬁbrin  [98],  and  polysaccharide  [99]  pro-
vides  optimal  mechanical  properties  and  the  ability  to
control  cell  functions  [100].  Recently,  click  chemistry  has
been  utilised  in  the  design  of  new  biodegradable  polymers
with  improved  mechanical  strength  and  with  easily  clickable
surfaces  for  biofunctionalisation  [101].  Sun  et  al.  developed
a  composite  of  HAp  and  clickable  biodegradable  polymers
as  a  novel  class  of  orthopaedic  biomaterial  that  offers  dis-
tinct  advantages  for  bone  tissue  engineering  applications
[102].
Powder  metallurgy  processing  of  HAp  nanocrystals  with
other  inorganic  materials  such  as  metals  (especially  tita-
nium  (Ti)  [103])  or  metal  oxides  (ZrO2 [104,105],  TiO2
[106],  and  Al2O3 [107])  has  also  been  developed  to  improve
the  mechanical  characteristics  of  HAp  ceramics  or  to  the
improve  biocompatibility  of  metals  or  metal  oxides.
The  overall  structural  design  of  the  composite  from  the
nanoscale  to  the  macroscale  level  is  important  for  con-
trolling  its  mechanical  and  physiochemical  properties.  HAp
composites  are  generally  fabricated  by  mixing  HAp  parti-
cles  with  a  matrix.  However,  the  bioactivity  of  HAp  can
be  hindered  because  most  of  the  HAps  are  buried  inside
the  composite  matrix  by  simple  mixing  methods.  To  coat
well-crystallised  HAp  on  a  broad  range  of  substrates,  the
nanocrystal  coating  method  has  been  developed  [108,109].
The  HAp  nanocrystal  coating  has  been  applied  to  percu-
taneous  devices  [110]  and  injectable  cell  scaffolds  [111].
Freeze  casting  processing  and  additive  manufacturing  have
been  used  for  fabricating  nanocomposite  structures  inspired
by  natural  materials  (such  as  nacre  or  the  stomatopod  club)
to  improve  the  stiffness,  strength,  and  toughness  of  the
structure  [112].
4.3.  Carriers  for  drug,  protein,  and  gene  delivery
HAp  nanoparticles  have  been  investigated  as  a  carrier
for  growth  factors  [113,114],  antibiotics  [115,116], and
anticancer  drugs  [117,118].  The  adsorption/desorption
characteristics  [114,119,120]  and  conformational  changes
[121—123]  of  various  types  of  proteins  (or  peptides)  on  HAp
surfaces  have  been  studied.  Computational  (in  silico) studies
have  been  used  to  clarify  the  interaction  between  proteins
(or  peptides)  and  HAp  surfaces  [124—126].
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Calcium  phosphate  (CaP)-deoxyribonucleic  acid  (DNA)
o-precipitation  has  been  used  for  in  vitro  gene  trans-
ection  because  of  the  biocompatible,  biodegradable,  and
asy-to-handle  nature  of  CaP  [127].  To  achieve  effective
ene  transfection,  HAp  nanoparticles  can  be  also  utilised
s  gene  carriers  because  of  their  good  ability  to  absorb  DNA
olecules  [128,129].
.4.  Reparative  materials  for  damaged  enamel
he  application  of  HAp  to  repair  damaged  enamel  has
ecently  attracted  attention  in  the  dental  ﬁeld  because
f  the  chemical  and  structural  similarity  of  HAp  to  tooth
inerals  [130,131]. Li  et  al.  showed  that  remineralisa-
ion  increased  by  using  20-nm  HAp  over  several  hundred
anometer-sized  HAp  or  20-nm  amorphous  calcium  phos-
hate  (ACP)  [132].  Recent  research  by  Huang  et  al.
as  demonstrated  that  HAp  nanoparticles  have  a  re-
ineralisation  effect  on  an  initial  caries  lesion,  similar  to
hat  of  ﬂuoride  [133]. Kim  et  al.  examined  the  effect  of
arbonate  apatite  nanoparticles  to  prevent  re-staining  and
lterations  of  the  enamel  surface  after  dental  bleaching
134].
.  Summary and future perspectives
ynthetic  HAp  is  a  beneﬁcial  material  for  dental  and
edical  applications.  The  use  of  HAp  nanoparticles  has
any  advantages  over  conventional-sized  HAp  bulk  ceram-
cs  based  on  the  large  surface-to-volume  ratio,  reactivity,
nd  biomimetic  morphology  of  the  HAp  nanoparticles  for
pplications  such  as  ﬁllers  for  composites,  carriers  for  drugs,
nd  reparative  materials  for  damaged  enamel.  Numerous
ethods  have  evolved  in  the  past  few  decades  to  fab-
icate  more  effective  HAp  nanoparticles  and  composites.
mprovement  in  the  dispersion  of  HAp  nanoparticles  in  liquid
edium  (or  solid  matrices)  is  important  for  the  applica-
ion  of  HAp  in  the  nanoparticle  form  and  as  HAp-ﬁlled
omposites  [135]. Although  the  dispersion  ability  has  been
mproved  by  adding  surfactant  molecules,  it  is  necessary
o  develop  another  approach  because  of  the  toxicity  of
he  surfactant  molecules.  Recent  progress  in  computational
nalyses  for  conformational  changes  of  proteins  interacting
ith  HAp  surfaces  that  alter  the  structure  and  function
f  a  distant  active  site  will  work  as  a  guide  for  design-
ng  nanostructured  HAp  surfaces  to  transcend  the  chemistry
f  natural  minerals.  Although  nanostructured  biomaterials
ave  many  potential  advantages,  it  is  important  to  remem-
er  that  the  inﬂuence  of  nanoparticles  on  human  health  is
ot  well  understood,  regardless  of  whether  exposure  occurs
hrough  the  manufacture  or  implantation  of  nanomaterials.
hus,  further  understanding  the  biological  inﬂuence  of  nano-
ized  HAp  is  essential  for  the  development  of  their  future
pplications.onﬂict of interest statement
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